Advertisement

Topics

Gryphon Sciences Company Profile

17:41 EDT 23rd September 2017 | BioPortfolio

Gryphon can generate novel or improved protein therapeutics using chemistry alone. This positions Gryphon to benefit from the revolution in genomics and proteomics that has identified countless new potential protein therapeutics.

Gryphon uses two technologies that allow it to rapidly produce proteins of medical interest. These technologies form a powerful drug development platform, which Gryphon has used to address large commercial markets. Our products combine chemically synthesized protein backbones with precision length polymers (PLPs) to create potent medications. The use of chemistry, rather than biology, allows us to manipulate protein drugs in ways that were never before possible. Gryphon has introduced changes to the molecules, which result in their increased potency, and duration in the circulatory system. Efficient-scalable processes with high yields make this a cost effective way to manufacture valuable drugs.

Location

250 E. Grand Avenue Suite 90
South San Francisco
CA
94080
United States of America

Contact

Phone: 415 952 7714
Fax: 415 952 3055
Email: info@gryphonsci.com


News Articles [473 Associated News Articles listed on BioPortfolio]

Gryphon Investors’ CORA Health Services Expands into Georgia

Completes Five Add-on Acquisitions of Five Physical Therapy Companies In 2017 CORA Health Services, Inc. (“CORA”), a top 10 national operator of outpatient physical...

Gryphon Investors To Acquire Ob Hospitalist Group from Ares Management

Gryphon Investors (“Gryphon”), a San Francisco-based private equity firm, and Ares Management, L.P. (“Ares”) (NYSE:ARES) today announced that Gryphon will acquire Ob Hospi...

CV Sciences, Inc. Announces Commencement of IND preparation immediately following Pre-IND ...

LAS VEGAS, NV--(Marketwired - June 19, 2017) -CV Sciences, Inc. ( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we"), today Read more...

CV Sciences, Inc. Announces Webcast for Investor Update Call

LAS VEGAS, NV--(Marketwired - September 11, 2017) -CV Sciences, Inc., ( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we") Read more...

CV Sciences, Inc. to Present at MJAC2017 InvestorsHub International Cannabis Conference

LAS VEGAS, NV--(Marketwired - August 28, 2017) -CV Sciences, Inc. ( OTCQB : CVSI) ("CV Sciences," "our" or "we"), is pleased to Read more...

CV Sciences, Inc. Highlights Recent Research Showing Cannabidiol May Reduce Relapses in ...

LAS VEGAS, NV--(Marketwired - August 15, 2017) -CV Sciences, Inc.( OTCQB : CVSI) (the "Company," "CV Sciences," "our" or "we") highlighted Read more...

Smile Brands Partners with Premier Santa Barbara-Area Group Practice

Smile Brands Inc., based in Irvine, California, announced today that it has completed an add-on acquisition, partnering with Johnson Family Dental (“JFD”). JFD is a leading de...

Lords Committee Launches New Inquiry into Life Sciences and the Industrial Strategy

The House of Lords Science and Technology Committee invites contributions to its new inquiry - Life Sciences and the Industrial Strategy. The Government set out in its Industrial Strategy Green Paper ...

Clinical Trials [147 Associated Clinical Trials listed on BioPortfolio]

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir and Ledipasvir from M...

Companies [1019 Associated Companies listed on BioPortfolio]

Gryphon Sciences

Gryphon can generate novel or improved protein therapeutics using chemistry alone. This positions Gryphon to benefit from the revolution in genomics and proteomics that has identified countless new po...

Gryphon Investors

Based in San Francisco, Gryphon Investors focuses on leveraged acquisitions of, and growth investments in, middle-market companies in partnership with experienced management. Havi...

Gryphon House, Inc.

Gryphon House, Inc., is an award-winning publisher of resource books for parents and teachers of children from birth through age eight. Developmentally appropriate and easy...

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

More Information about "Gryphon Sciences" on BioPortfolio

We have published hundreds of Gryphon Sciences news stories on BioPortfolio along with dozens of Gryphon Sciences Clinical Trials and PubMed Articles about Gryphon Sciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gryphon Sciences Companies in our database. You can also find out about relevant Gryphon Sciences Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record